Clinical trial
Study on Serum IGF1 in Female Patients With Heart Failure With Preserved Ejection Fraction
NCT07015554 is registered in ClinicalTrials.gov with The University of Hong Kong-Shenzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Serum IGF1 in Female Patients With Heart Failure With Preserved Ejection Fraction
- Lead sponsor
- The University of Hong Kong-Shenzhen Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hfpef - heart failure with preserved ejection fraction